Aerovate(AVTE.US) Officer Sells US$84,331.5 in Common Stock
$Aerovate(AVTE.US)$ Officer Gillies Hunter sold 4,000 shares of common stock on May 17, 2024 at an average price of $21.0829 for a total value of $84,331.5.Source: Announcement What is statement of ch
Aerovate(AVTE.US) Officer Sells US$215.76K in Common Stock
$Aerovate(AVTE.US)$ Officer NOYES TIMOTHY P sold 10,000 shares of common stock on May 16, 2024 at an average price of $21.5755 for a total value of $215.76K.Source: Announcement What is statement of c
Form 144 | Aerovate(AVTE.US) Officer Proposes to Sell 215.76K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Aerovate(AVTE.US)$ Officer TIMOTHY NOYES intends to sell 10,000 shares of its common stock on May 16, with a total market value of approximately $215.76K. TIMOTHY NO
Wedbush: Reiterates Aerovate Therapeutics (AVTE.US) rating, adjusted from better than market to better than market rating, with a target price of $41.00.
Wedbush: Reiterates Aerovate Therapeutics (AVTE.US) rating, adjusted from better than market to better than market rating, with a target price of $41.00.
Wedbush Reiterates Outperform on Aerovate Therapeutics, Maintains $41 Price Target
Wedbush analyst Laura Chico reiterates Aerovate Therapeutics (NASDAQ:AVTE) with a Outperform and maintains $41 price target.
Aerovate Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 114.21% Wedbush → $41 Reiterates Outperform → Outperform 04/01/2024 82.86% Wells Fargo $35 → $3
Wedbush Remains a Buy on Aerovate Therapeutics (AVTE)
Aerovate | 10-Q: Quarterly report
Aerovate Therapeutics Q1 2024 GAAP EPS $(0.83) Misses $(0.74) Estimate
Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.74) by 12.16 percent.
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Enrollment continues into the Phase 3 portion of the
Aerovate Therapeutics 1Q Loss/Shr 83c >AVTE
Aerovate Therapeutics 1Q Loss/Shr 83c >AVTE
Aerovate(AVTE.US) Officer Sells US$41,630.72 in Common Stock
$Aerovate(AVTE.US)$ Officer Verwijs Marinus sold 1,981 shares of common stock on May 2, 2024 at an average price of $21.015 for a total value of $41,630.72.Source: Announcement What is statement of ch
Aerovate(AVTE.US) Officer Sells US$230.95K in Common Stock
$Aerovate(AVTE.US)$ Officer NOYES TIMOTHY P sold 11,357 shares of common stock on May 1, 2024 at an average price of $20.3351 for a total value of $230.95K.Source: Announcement What is statement of ch
Form 144 | Aerovate(AVTE.US) Officer Proposes to Sell 230.94K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Aerovate(AVTE.US)$ Officer TIMOTHY NOYES intends to sell 11,357 shares of its common stock on May 1, with a total market value of approximately $230.94K. TIMOTHY NOYE
Aerovate(AVTE.US) Officer Sells US$153.33K in Common Stock
$Aerovate(AVTE.US)$ Officer Dake Benjamin T sold 6,853 shares of common stock on Apr 17, 2024 at an average price of $22.3737 for a total value of $153.33K.Source: Announcement What is statement of ch
Aerovate(AVTE.US) Officer Sells US$89,521.83 in Common Stock
$Aerovate(AVTE.US)$ Officer Gillies Hunter sold 4,000 shares of common stock on Apr 17, 2024 at an average price of $22.3805 for a total value of $89,521.83.Source: Announcement What is statement of c
Aerovate(AVTE.US) Officer Sells US$246.97K in Common Stock
$Aerovate(AVTE.US)$ Officer NOYES TIMOTHY P sold 10,000 shares of common stock on Apr 16, 2024 at an average price of $24.6971 for a total value of $246.97K.Source: Announcement What is statement of c
Form 144 | Aerovate(AVTE.US) Officer Proposes to Sell 246.97K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 16, $Aerovate(AVTE.US)$ Officer TIMOTHY NOYES intends to sell 10,000 shares of its common stock on Apr 16, with a total market value of approximately $246.97K. TIMOTHY NO
Aerovate(AVTE.US) Officer Sells US$201.39K in Common Stock
$Aerovate(AVTE.US)$ Officer Eldridge George A sold 7,500 shares of common stock on Apr 10, 2024 at an average price of $26.8522 for a total value of $201.39K.Source: Announcement What is statement of
Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing
David S. Grayzel, Director, on April 09, 2024, sold 11,882 shares in Aerovate Therapeutics (AVTE) for $334,478. Following the Form 4 filing with the SEC, Grayzel has control over a total of 1,799,232
No Data